GENE ONLINE|News &
Opinion
Blog

Phase III
ESMO 2024 Prostate CancerBayer
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Ranking & Reports Financemarket insights
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
Interviews AusBiotech
AusBiotech on Funding, Regulatory Navigation, International Expansion, and Clinical Trial Development in Australia’s Biotech Industry
2024-08-22
Asia-Pacific Pneumococcal Vaccine
SK Bioscience and Sanofi Advance Global Phase III Study for Pneumococcal Conjugate Vaccine
2023-12-11
LATEST
Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration
2025-03-21
European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1
2025-03-21
Study Examines Long-Term Effects of Anti-Amyloid Drug for Rare Alzheimer’s Variant
2025-03-21
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
Trump Administration Policies May Impact Health Care for Intersex Individuals
2025-03-21
Federal Health Care Research Agency Faces Potential Mass Layoffs
2025-03-21
Police and Hospitals’ Drug Confiscation Practices Examined
2025-03-21
READ MORE
EVENT
2025-04-02
Asia Cell and Gene Therapy Innovation Summit 2025
Shanghai, China
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top